Investor owns 6.6% of Rotech

Monday, June 20, 2011

ORLANDO – Wynnefield Capital Management owns 1,682,427 shares or 6.6% of the common stock of Rotech Healthcare, it reported in a June 9 Securities and Exchange Commission filing. Wynnefield Capital, a New York City-based investor, specializes in “U.S. small cap situations that have a company or industry specific catalyst(s),” according to its website. Wynnefield’s MO: “We seek out under-followed, unrecognized and undervalued companies that fit our parameters, which include minimal balance sheet risk and potential for micro or macro change.” Wynnefield’s holdings are worth $6.9 million, according to reports. Rotech announced June 14 that it plans to exchange up to $283.5 million in aggregate principal of its senior second lien notes due 2018 for private notes tendered by the holders of those notes. The exchange offer expires July 12.